COVID19 IMPACT Assessment of the impact of the COVID19 crisis on the therapeutic management of patients newly diagnosed with glioblastoma AND for stage IV pancreatic cancer
- Funded by ANR
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AFunder
ANRPrincipal Investigator
Gaëtane SimonResearch Location
FranceLead Research Institution
N/AResearch Priority Alignment
N/A
Research Category
Secondary impacts of disease, response & control measuresResearch Subcategory
Indirect health impactsSpecial Interest Tags
N/AStudy Type
ClinicalClinical Trial Details
Not applicableBroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified
Abstract
The IMPACT COVID19 project will study in detail the impact of the crisis linked to the Covid-19 pandemic on the diagnosis, care and survival of the very vulnerable population of patients with glioblastoma and pancreatic cancer, for whom any delay or change has a major impact. It provides for the collection of information on the course of care from the files of patients diagnosed and treated between 2018 and 2020 in centers of expertise.